ArticleFrontiers in endocrinology2025
Ensemble learning prediction model for intraoperative hemodynamic instability in patients with pheochromocytoma.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurately predicting intraoperative hemodynamic instability (HI) in patients with pheochromocytoma is essential for improving prognosis; however, clinically applicable large-sample, high-precision predictive models remain limited. This study develops and validates an ensemble learning (EL) model to predict HI risk. Methods: This cohort study included a derivation cohort (n = 353) and an external validation cohort (n = 51), from January 2011 to February 2023. General clinical and intraoperative hemodynamic data were collected. Ensemble feature selection was used to identify key predictors. 5-fold cross-validation was repeated 1000 times to develop the EL model. Shapley Additive Explanations was used to analyze feature contributions, and the model was implemented as a web calculator. The primary outcome was the occurrence of intraoperative HI, evaluated by area under the curve (AUC), sensitivity, specificity, and calibration. Results: Of 45 variables, tumor size, preoperative systolic blood pressure, age, fasting plasma glucose, and body mass index were top predictors. The developed EL model achieved AUC, sensitivity, and specificity values of 0.886, 0.776, and 0.836 and 0.744, 0.733, and 0.667 in Training set and external validations, respectively. Higher SBP (≥ 125 mmHg), larger tumor size (≥ 60 mm), older age (≥ 55 years), higher FPG (≥ 6 mmol/L), and BMI <22 or >30 kg/m² increased HI risk. The model demonstrated strong calibration and is accessible at http://60.205.91.235/. Conclusions: This study identified five key predictors of intraoperative HI in patients with pheochromocytoma. The developed EL model provides an accurate, clinically applicable HI risk estimation tool, potentially improving clinical management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.